HOME >> BIOLOGY >> NEWS
Nov. 18-21 nanotechnology conference in Irvine, Calif.

Research on nanotechnology is under way in a wide range of disciplines, from cell biology to computer engineering to optics. At this conference, 100 leading researchers will gather in focus groups to discuss and try to solve some major challenges facing nanotechnology today, including the building of a nano-system that can multiply and isolate RNA or DNA; the building of a synthetic self-replicator; and the development of a system to detect disease in vivo. Conference attendees will be eligible to compete for $1 million in research grants.

DETAILS: Nov. 18-21 at the Arnold and Mabel Beckman Center, 100 Academy Drive, Irvine, Calif. CONFERENCE ATTENDANCE IS BY INVITATION ONLY. SESSIONS LISTED BELOW ARE OPEN TO MEDIA. SPACE IS LIMITED AND MEDIA MUST REGISTER IN ADVANCE.

ON THURSDAY, NOV. 18:

7 P.M. TO 9 P.M. PLENARY SESSIONS on Theory and Error Correction, presented by Peter Wolynes, University of California at San Diego, and an Overview of Cell Biology, presented by Thomas D. Pollard, Yale University.

ON FRIDAY, NOV. 19:

8:30 A.M. TO 9 A.M. OPENING CEREMONY. Speakers include Wm. A. Wulf, president, National Academy of Engineering; Richard N. Foster, board member, W.M. Keck Foundation; and Cherry Murray, senior vice president of physical sciences research, Bell Laboratories, Lucent Technologies, and chair, Conference Steering Committee.

9 A.M. TO 10 A.M. PUBLIC BRIEFING. The new National Academies report FACILITATING INTERDISCIPLINARY RESEARCH examines the scope of current cross-disciplinary research and recommends ways to encourage communication among scientists. It will be released simultaneously in Washington, D.C., and Irvine, Calif. Reporters who cannot attend may listen to a live audio webcast of the briefing and submit questions using an e-mail form at http://national-academies.org.

7 P.M. TO 9 P.M. AWARDS PRESENTATION. Winners of this year's
'"/>

Contact: Maureen O'Leary
NEWS@nas.edu
202-334-2138
The National Academies
15-Oct-2004


Page: 1 2

Related biology news :

1. EPA foregoes opportunity to improve nanotechnology oversight
2. EPA and nanotechnology: Oversight for the 21st century
3. Iowa State scientists demonstrate first use of nanotechnology to enter plant cells
4. New report explores nanotechnologys future
5. Will nanotechnology revolutionize medicine?
6. Wilson Center and Pew Charitable Trusts expand efforts to examine risks/benefits of nanotechnology
7. Survey finds emotional reactions to nanotechnology
8. Understanding occupational safety and health issues of nanotechnology
9. Researchers probe health and safety impacts of nanotechnology
10. New nanotechnology able to examine single molecules, aiding in determining gene expression
11. Scientist Andrew Maynard to testify on nanotechnology research needs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Nov nanotechnology conference Irvine Calif

(Date:2/10/2015)... 2015  Alere Inc. (NYSE: ALR), a global ... for the quarter ended December 31, 2014. ... of Alere said, "We made substantial progress in ... global leader in rapid diagnostics and delivering against ... divestiture in early January enabled us to substantially ...
(Date:2/5/2015)... PARK, N.C. , Feb. 5, 2015  Marken ... specialist logistics company and has launched a new marketing ... Clinical Logistics Organization (CLO).  The new campaign focuses on ... on patient, protocol and shipments. The first ... , aligns Marken,s priorities with its client,s priorities. ...
(Date:2/5/2015)... Jan. 27, 2015   Marvin Test ... deployed, innovative test solutions for military, aerospace, ... of its TS-323 GENASYS Test Platform ... (LMSSC). GENASYS is a high-performance PXI-based system ... applications that require performance functional testing. GENASYS ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
(Date:2/27/2015)... Nova Scotia (PRWEB) February 27, 2015 ... been made aware of a fraudulent press release disseminated ... purporting to be from Immunovaccine. This press release states ... Gilead Science, Inc. The press release did not ... the information contained within the press release. Please ...
(Date:2/27/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) ... of Trypsin" report to their offering. , ... providing comprehensive data on Trypsin globally and regionally ( ... North America , Latin America ... Trypsin This report focuses on three primary areas; ...
(Date:2/27/2015)... -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company ... that it will be presenting at CALBIO 2015 at ... at 3pm PST. Patrick Lucy, chief business officer of ... state of the biosimilar industry landscape entitled The ... more information on CALBIO 2015 and The Evolving ...
(Date:2/27/2015)... PureTech , a science and technology R&D company focused  ... in the healthcare sector, announced today the appointment of ... the Board of Directors of Sanofi, to its Board ... pleasure to know Chris for many years and I ... more closely now," said Dr. Robert Langer , ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4
Cached News: